Interferon-α Therapy and Anti-Human Leukocyte Antigen Antibodies in Hepatitis C Virus-Positive Patient: Case Report

Transplantation Proceedings

Volumn 39, Issue 6, 2007, Pages 2040-2041

  Cervelli, C ^a   Fontecchio, G ^a   Fioroni, M A ^a   Azzarone, R ^a   Battistoni, C ^a   Maccarone, D ^c   Pisani, F ^b   Papola, F ^a  

^a Centro Regionale di Immunoematologia e Tipizzazione Tissutale   (Italy)

^b Ferrara   (Italy)

^c Centro Regionale Trapianti   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; HLA ANTIBODY;

ANTIBODY PRODUCTION; ANTIBODY SPECIFICITY; ANTIVIRAL THERAPY; ARTICLE; CONTROLLED STUDY; CYTOFLUOROMETRY; DONOR; GRAFT RECIPIENT; GRAFT REJECTION; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; IMMUNITY; PRIORITY JOURNAL; RISK; SERUM;

ANGIOGENESIS INHIBITORS; AUTOANTIBODIES; FLOW CYTOMETRY; HEPATITIS C; HISTOCOMPATIBILITY ANTIGENS CLASS I; HLA ANTIGENS; HLA-D ANTIGENS; HUMANS; INTERFERON-ALPHA;

EID: 34547568876     PISSN: 00411345     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.transproceed.2007.05.013     Document Type: Article

References (4)

1. Morales J.M., and Campistol J.M. Transplantation in the patient with hepatitis C. J Am Soc Nephrol 11 (2000) 1343
2. Baids S., Tolkoff-Rubin N., Saidman S., et al. Acute humoral rejection in hepatitis C-infected renal transplant recipients receiving antiviral therapy. Am J Transplant 3 (2003) 74
3. Le Bon A., Sciavoni G., D'Agostino G., et al. Type I interferons potently enhance humoral immunity and can promote isotype switching by stimulating dendritic cells in vivo. Immunity 14 (2001) 461
4. Yamaji K., Nabeshima S., Murata M., et al. Interferon-alpha/beta upregulate IL-15 expression in vitro and in vivo: analysis in human hepatocellular carcinoma cell lines and in chronic hepatitis C patients during interferon-alpha/beta treatment. Cancer Immunol Immunother 55 (2006) 394